Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis

@article{Fattore2016SyntheticCE,
  title={Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis},
  author={Liana Fattore},
  journal={Biological Psychiatry},
  year={2016},
  volume={79},
  pages={539-548}
}
  • L. Fattore
  • Published 1 April 2016
  • Psychology, Medicine
  • Biological Psychiatry
Synthetic Cannabinoid Use
TLDR
Early evidence suggests that adverse somatic and psychiatric outcomes associated with the use of SCs may be more prevalent and more severe than those arising from cannabis use.
Cannabinoids and psychosis: current challenges of mechanistic toxicology
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
TLDR
Given the rapid increase in the use of synthetic cathinones and cannabinoid designer drugs, their potential for dependence and abuse, and harmful medical and psychiatric effects, there is a need for research and education in the areas of prevention and treatment.
Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis
TLDR
This study shows that SC use is associated with increased mental health symptomatology compared to NC use, and scored higher than NC users on all used psychometric measures, indicating a higher likelihood of drug abuse, sleep problems, (hypo)manic symptoms, and the nine dimensions of BSI.
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
TLDR
Given the growing popularity in the use of cannabinoid-based drugs and their harmful potential, there is a need for further research in this field.
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
TLDR
Irrespective of whether use of cannabis is decriminalized or legalized, the evidence that it is a component cause of psychosis is now sufficient for public health messages outlining the risk, especially of regular use of high‐potency cannabis and synthetic cannabinoids.
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
TLDR
The findings of this review confirm the importance of prompt and reliable information available for health professionals and more specific analytic techniques and designed preventive strategies are required to face unprecedented SC challenge.
Old and new synthetic cannabinoids: lessons from animal models
TLDR
Behavioral studies clearly indicate that synthetic cannabinoids possess abuse liability, are likely to activate the brain reward circuit and induce positive subjective and reinforcing effects.
The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
TLDR
Both pre-clinical and clinical studies demonstrated an association between synthetic cannabinoids and executive-function impairment either after acute or repeated consumptions of these drugs.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 121 REFERENCES
Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
TLDR
This case report examines the acute psychosis displayed by a psychiatric patient after smoking “Spice,” a substance comprised of various synthetic cannabinoids, on three separate occasions and explores the possibility that synthetic cannabinoids are more potent than their organic counterpart.
Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Novel psychoactive substances of interest for psychiatry
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine‐like
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
TLDR
The review shows that the use of SCRAs may cause more frequent and more severe unwanted negative effects, especially in younger, inexperienced users, and studies on the relative risk ofSCRAs compared with natural cannabis to induce or evoke psychosis are urgently needed.
Beyond THC: The New Generation of Cannabinoid Designer Drugs
TLDR
An escalating number of compounds with cannabinoid receptor activity are currently being found as ingredients of Spice, of which almost nothing is known in terms of pharmacology, toxicology, and safety.
The Synthetic Cannabinoid Withdrawal Syndrome
TLDR
The acute withdrawal syndrome appears to be characterized mainly by anxiety and tachycardia in the absence of any neurological findings or electrolyte disturbances.
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series
TLDR
This manuscript provides an overview and discussion of synthetic cannabinoids and presents four cases of patients with synthetic cannabinoid intoxication who were hospitalized in the authors' intensive psychiatric unit at the time of intoxication, with predominantly psychiatric adverse clinical effects.
Internet Highs—Seizures After Consumption of Synthetic Cannabinoids Purchased Online
TLDR
The authors interpreted the history and findings consistent with the consumption of a large amount of synthetic cannabinoids leading to new-onset seizures and coma as a 48-year-old man who, after consuming the herbal blend, lost consciousness and suffered several episodes of seizures.
...
1
2
3
4
5
...